← Back to Clinical Trials
Recruiting NCT05952167

NCT05952167 Evaluation of the Impact of Tractions vs. Placebo Tractions in Patients With Cervical Radiculopathy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05952167
Status Recruiting
Phase
Sponsor Centre Hospitalier Departemental Vendee
Condition Radiculopathy
Study Type INTERVENTIONAL
Enrollment 206 participants
Start Date 2024-03-25
Primary Completion 2030-12-25

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Intensive cervical traction protocolIntensive cervical traction protocol - placebo

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 206 participants in total. It began in 2024-03-25 with a primary completion date of 2030-12-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Cervical radiculopathy is a common disease related to compression of the nerve roots of the spine (prevalence: 3.5/1000). Dysfunction and pain are the main repercussions and can lead to time off work and high costs in terms of treatment. Second-line surgical treatments appear to be less effective and present risks of side effects. In the first instance, treatments are conservative and include medication but above all physiotherapy with manual therapy, muscle exercises and cervical traction. These cervical tractions performed by a physiotherapist require little equipment and are inexpensive compared with the surgical alternative. They involve stretching the cervical spine and soft tissues to open the intervertebral foramen and mobilise the facet joints. Several authors have written summaries of their interest. Thoomes reports two studies and describes an absence of effect. In a meta-analysis, Romeo et al. added three more recent studies to the previous review and concluded that traction is effective, highlighting an "effect-dose" relationship. These recent results therefore seem to reverse the recommendations made barely two years later. Nevertheless, almost all the studies compared "manual therapy + exercises" with "manual therapy + exercises + cervical traction". Only Young et al. tested "manual therapy + exercises + cervical traction at an effective weight" compared to "manual therapy + exercises + cervical traction placebo at an ineffective weight". The study did not reveal any difference between the groups. However, several limitations appear in this study when comparing the protocol to studies that have shown efficacy. The main limitation is the low intensity (i.e. protocol with fewer sessions and longer duration). These clinical limitations may explain the lack of evidence of a positive outcome. Following on from a preliminary study evaluating an intensive cervical traction protocol over five days, and in order to discern the effect specific to the treatment (specific effect) and the effect independent of the nature of the treatment (contextual effect), the investigators wish to evaluate the impact of this intensive protocol by comparing it with placebo traction. In current practice, treatment varies between establishments. The paucity of studies on cervical traction in radiculopathy has resulted in routine use being guided by habit rather than evidence. It remains a clinical question which raises a major issue requiring a robust experimental design. Ultimately, this study follows on from a preliminary study and is part of a comprehensive research project aimed at proposing new recommendations for the use of traction in patients suffering from cervical radiculopathy. The investigators are investigating the impact of an intensive traction vs. placebo traction protocol in patients with cervical radiculopathy.

Eligibility Criteria

Inclusion Criteria: * Patient over 18 * Neck Disability Index ≥ 15/50 * Presence of at least three of the four signs clinically validating the presence of cervical radiculopathy (Wainner et al. 2003) * a) upper limb nerve tension test A (ULNT1a): positive, * b) amplitude of cervical rotation on the side concerned: \< 60°, * c) positive cervical distraction test: relief * d) positive Spurling test: reproduction of symptoms. * Cervical radiculopathy diagnosed 3 to 24 months previously * Absence of cervical traction in the 5 years prior to inclusion * MRI or CT scan performed prior to hospitalisation in relation to current pathology * Patient able to understand the protocol and having given oral informed consent to take part in the research. * Patient affiliated to the social security system or entitled beneficiary. Exclusion Criteria: * Patients with vertebral artery pathology at the time of inclusion * Patients with myelopathy, cervical cancer, cervical fracture, cervical dislocation, cervical spondylolisthesis, spinal infection, symptomatic cervical pain without radiculopathy and/or cervical surgery in the 2 years prior to inclusion. * Patient participating in another clinical research protocol with an impact on the objectives of the research. * Patient who is pregnant, breastfeeding or able to procreate without effective contraception\*. * Patient under guardianship, curatorship or deprived of liberty * Patient under activated future protection mandate * Patient under family habilitation * Patient under court protection.

Contact & Investigator

Central Contact

Chloé MOREAU

✉ chloe.moreau@ght85.fr

📞 0251446327

Principal Investigator

Thomas RULLEAU

PRINCIPAL INVESTIGATOR

Nantes University Hospital

Frequently Asked Questions

Who can join the NCT05952167 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05952167 currently recruiting?

Yes, NCT05952167 is actively recruiting participants. Contact the research team at chloe.moreau@ght85.fr for enrollment information.

Where is the NCT05952167 trial being conducted?

This trial is being conducted at La Roche-sur-Yon, France, La Rochelle, France, Le Puy-en-Velay, France, Limoges, France and 4 additional locations.

Who is sponsoring the NCT05952167 clinical trial?

NCT05952167 is sponsored by Centre Hospitalier Departemental Vendee. The principal investigator is Thomas RULLEAU at Nantes University Hospital. The trial plans to enroll 206 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology